In one case a firm is alleged to have improperly billed the COVID-19 Uninsured Program while in the other a firm paid and received kickbacks for unnecessary genetic testing.

A number of the Dutch firm's products have received certification under Europe's In Vitro Diagnostic Regulation recently.

NEW YORK – Impacts from China's volume-based procurement program and other healthcare pricing reforms led to flat Q1 diagnostics revenues year over year for Roche, company executives said Thursday.

The company said during a conference call following release of its Q1 2025 results that it purchases roughly 80 percent of ...

SSID Group said that the assets acquired in the deal will complement its gastric health portfolio and let it offer a broader range of tests to US labs.

NEW YORK – Roche announced on Wednesday that it has received CE marking for its Chest Pain Triage algorithm to help rule in and rule out heart attacks in the emergency department.

The Canadian firm’s SpineStat assay is used to detect autoantibodies to the protein biomarker 14-3-3eta to aid the diagnosis of axial spondyloarthritis.

The firm also reported its Life Sciences segment revenues fell 4 percent in the quarter, while Diagnostics revenues decreased 3 percent.

The company has completed its FDA submission for the system and inked a deal with UAE-based healthcare provider Burjeel Holdings to deploy the system in its facilities.

The Australian precision diagnostics firm said it will use the money to support the launch of its proteomic tests in Australia and the US.

The Swiss healthcare firm said that the money will be used to expand its R&D, manufacturing, and distribution operations in the US.